Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19

Christophe Guervilly1,2, Stephane Burtey3,4, Florence Sabatier4,5,6

  • 1Medical Intensive Care Unit, North Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Insights

Severe COVID-19 is linked to increased circulating endothelial cells (CECs), indicating significant vascular and endothelial injury. This finding highlights endothelial damage as a critical aspect of severe coronavirus disease 2019.

Area of Science:

  • Vascular Biology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) commonly presents with pulmonary symptoms.
  • However, significant vascular events have been increasingly reported in COVID-19 patients.
  • The role of endothelial cells in severe COVID-19 requires further investigation.

Purpose of the Study:

  • To investigate the association between circulating endothelial cells (CECs) and severe forms of COVID-19.
  • To determine if elevated CEC levels correlate with disease severity markers.

Main Methods:

  • Retrospective study including 99 patients diagnosed with COVID-19.
  • Comparison of CEC counts between intensive care unit (ICU) and non-ICU patients.
  • Correlation analysis between CEC levels and markers of disease severity and inflammation.

Main Results:

  • Patients in the ICU exhibited significantly higher CEC counts compared to non-ICU patients.
  • The extent of endothelial injury, indicated by CEC levels, correlated with markers of disease severity.
  • Elevated CEC counts were associated with increased levels of inflammatory cytokines.

Conclusions:

  • Endothelial injury is a significant and demonstrable feature of severe COVID-19.
  • Increased circulating endothelial cells serve as a biomarker for endothelial damage in COVID-19.
  • These findings underscore the importance of vascular complications in COVID-19 pathogenesis.

Related Concept Videos